ALT R&D Expense Growth
Altimmune Inc · R&D Expense Growth
ALT R&D Expense Growth
Latest reported-19.21%period ending
ALT FY R&D Growth (YoY) (0.00% → -19.21%)
Latest values, visible window
High-resolution chart · PNG
ALT r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -19.208% | |
| 24.9654% | |
| -6.7184% | |
| -5.3702% | |
| 49.7579% | |
| 180.1733% | |
| -3.7583% | |
| 0.2878% | |
| 280.6079% | |
| -5.7948% | |
| -44.9184% | |
| -39.0468% | |
| -21.6277% | |
| -8.0595% | |
| 1.6494% | |
| -30.9209% | |
| -5.0064% | |
| 92.1079% | |
| 0% | |
| 0% | |
| 0% |